Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
St Pharm CoXKRX:237690 +0.87%96 PB Ratio is 3.08 as of Sep. 21, 2026, which is 14% below its 10-year median of 3.57. GuruFocus rates XKRX:237690 with a GF Score™ of 96/100 and a GF Value™ of ₩115,775.72 (Modestly Undervalued). Among 922 Drug Manufacturers companies, St Pharm Co ranks worse than 67.79% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-21), St Pharm Co's share price is ₩92700.00. St Pharm Co's Book Value per Share for the quarter that ended in Jun. 2026 was ₩30,132.77. Hence, St Pharm Co's PB Ratio of today is 3.08.
Good Sign:
St Pharm Co Ltd stock PB Ratio (=2.98) is close to 5-year low of 2.93.
The historical rank and industry rank for St Pharm Co's PB Ratio or its related term are showing as below:
XKRX:237690'
s PB Ratio Range Over the Past 10 Years
Min: 0.83 Med: 3.57 Max: 8.99
Current: 3.07
During the past 13 years, St Pharm Co's highest PB Ratio was 8.99. The lowest was 0.83. And the median was 3.57.
XKRX:237690's PB Ratio is ranked worse than 67.79% of 922
companies
in the Drug Manufacturers industry
Industry Median: 2.015
vs XKRX:237690: 3.07
During the past 12 months, St Pharm Co's average Book Value Per Share Growth Rate was 21.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 16.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 12.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of St Pharm Co was 82.50% per year. The lowest was -5.60% per year. And the median was 8.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
St Pharm Co PB Ratio Related Terms
St Pharm Co PB Ratio Historical Data
* Premium members only.
The historical data trend for St Pharm Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
St Pharm Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where St Pharm Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
St Pharm Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
St Pharm Co (XKRX:237690) has a PB Ratio of 3.08 as of Sep. 21, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on St Pharm Co and its competitors. This is 14% below median its historical median of 3.57. Over the past decade, St Pharm Co's PB Ratio has ranged from 0.83 to 8.99. According to the industry distribution chart, St Pharm Co ranks #625 out of 922 companies in the Drug Manufacturers industry, placing it in the top 67.8%.
Is St Pharm Co's PB Ratio too high?
St Pharm Co's current PB Ratio of 3.08 is 14% below median its 10-year median of 3.57. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 8.99. The Drug Manufacturers industry median PB Ratio is 2.02. St Pharm Co's value of 3.08 is 52.9% above this industry median. Based on the distribution chart, St Pharm Co ranks #625 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, St Pharm Co has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does St Pharm Co's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, St Pharm Co ranks #625 out of 922 companies for PB Ratio. This places St Pharm Co in the lower half of its industry. The industry median PB Ratio is 2.02. St Pharm Co's value of 3.08 is 52.9% above this benchmark. Historically, St Pharm Co's own PB Ratio has ranged from 0.83 to 8.99 over the past decade. While the company's 10-year median is 3.57 vs. the industry median of 2.02, St Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 2.02, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. St Pharm Co's current PB Ratio of 3.08 is 52.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on St Pharm Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. St Pharm Co's current PB Ratio is 3.08, which is 14% below median its own 10-year median of 3.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is St Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, St Pharm Co (XKRX:237690) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩115,775.72, compared to a current price of ₩92,700.00 — trading 19.9% below its estimated fair value. The current PB Ratio is 3.08, which is 14% below median its 10-year median of 3.57 and 52.9% above the Drug Manufacturers industry median of 2.02. St Pharm Co's overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For St Pharm Co (XKRX:237690), the current PB Ratio is 3.08 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is St Pharm Co (XKRX:237690) Overvalued in 2026?
Based on GuruFocus' analysis, St Pharm Co stock appears to be undervalued.
The current stock price of ₩92,700.00 is trading 19.9% below its estimated GF Value™ of ₩115,775.72.
GuruFocus considers St Pharm Co to be Modestly Undervalued.
Key valuation signals for XKRX:237690:
PB Ratio: 3.08 (14% below median its 10-year median of 3.57)
GF Value™: ₩115,775.72 vs. price of ₩92,700.00 (19.9% below fair value)
Industry Position: 52.9% above the Drug Manufacturers median (#625 of 922)
No single metric tells the full story. See the XKRX:237690 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.
96GF Score
Get the complete analysis for XKRX:237690
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:237690 has been successfully added to your 
